Published in Biomaterials on March 31, 2012
Full-Length Fibronectin Drives Fibroblast Accumulation at the Surface of Collagen Microtissues during Cell-Induced Tissue Morphogenesis. PLoS One (2016) 1.40
Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A (2012) 0.95
Cell-derived matrices for tissue engineering and regenerative medicine applications. Biomater Sci (2015) 0.92
Tubular heart valves from decellularized engineered tissue. Ann Biomed Eng (2013) 0.92
Mechanoregulation of valvular interstitial cell phenotype in the third dimension. Biomaterials (2013) 0.84
New technologies for surgery of the congenital cardiac defect. Rambam Maimonides Med J (2013) 0.83
Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci (2015) 0.81
Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering. J Biomed Mater Res A (2012) 0.80
Heart Valve Replacements with Regenerative Capacity. Transfus Med Hemother (2016) 0.80
Cardiovascular Regenerative Technologies: Update and Future Outlook. Transfus Med Hemother (2016) 0.80
Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin Biol Ther (2015) 0.79
Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices. Tissue Eng Part C Methods (2015) 0.79
Tissue-engineered heart valve with a tubular leaflet design for minimally invasive transcatheter implantation. Tissue Eng Part C Methods (2014) 0.78
Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization. Biomed Eng Online (2013) 0.78
Decellularized periodontal ligament cell sheets with recellularization potential. J Dent Res (2014) 0.78
Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves. Tissue Eng Part C Methods (2015) 0.77
How to make a heart valve: from embryonic development to bioengineering of living valve substitutes. Cold Spring Harb Perspect Med (2014) 0.77
Effect of carbodiimide cross-linking of decellularized porcine pulmonary artery valvular leaflets. Int J Clin Exp Med (2014) 0.75
CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture. Biomed Mater (2015) 0.75
Cyclic Stretch and Perfusion Bioreactor for Conditioning Large Diameter Engineered Tissue Tubes. Ann Biomed Eng (2015) 0.75
Living-engineered valves for transcatheter venous valve repair. Tissue Eng Part C Methods (2014) 0.75
Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine. Adv Healthc Mater (2015) 0.75
Improved Geometry of Decellularized Tissue Engineered Heart Valves to Prevent Leaflet Retraction. Ann Biomed Eng (2015) 0.75
Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease. J Clin Med (2015) 0.75
Current Challenges in Translating Tissue-Engineered Heart Valves. Curr Treat Options Cardiovasc Med (2017) 0.75
Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum Mol Genet (2004) 2.42
Determination of the Poisson's ratio of the cell: recovery properties of chondrocytes after release from complete micropipette aspiration. J Biomech (2005) 2.29
Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease? Eur J Cardiothorac Surg (2010) 1.59
Influence of osmotic pressure changes on the opening of existing cracks in 2 intervertebral disc models. Spine (Phila Pa 1976) (2006) 1.49
Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng (2005) 1.32
Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units. Tissue Eng (2006) 1.29
How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg (2010) 1.26
Linear viscoelastic behavior of subcutaneous adipose tissue. Biorheology (2008) 1.25
A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol (2010) 1.22
Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol (2010) 1.19
Predicting local cell deformations in engineered tissue constructs: a multilevel finite element approach. J Biomech Eng (2002) 1.18
Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials (2005) 1.16
Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis (2002) 1.13
The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets--relevance for tissue engineering. Tissue Eng (2007) 1.12
Does subcutaneous adipose tissue behave as an (anti-)thixotropic material? J Biomech (2010) 1.10
Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices (2009) 1.10
A structural constitutive model for collagenous cardiovascular tissues incorporating the angular fiber distribution. J Biomech Eng (2005) 1.07
Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials (2013) 1.05
Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng (2006) 1.04
Advanced maturation by electrical stimulation: Differences in response between C2C12 and primary muscle progenitor cells. J Tissue Eng Regen Med (2010) 1.03
Mechanical characterization of anisotropic planar biological soft tissues using finite indentation: experimental feasibility. J Biomech (2007) 1.02
Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation (2006) 1.02
Improved prediction of the collagen fiber architecture in the aortic heart valve. J Biomech Eng (2005) 1.01
Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng (2002) 1.01
Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J (2010) 1.01
Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation (2006) 1.00
Tailoring fiber diameter in electrospun poly(epsilon-caprolactone) scaffolds for optimal cellular infiltration in cardiovascular tissue engineering. Tissue Eng Part A (2009) 1.00
Quantification of the temporal evolution of collagen orientation in mechanically conditioned engineered cardiovascular tissues. Ann Biomed Eng (2009) 1.00
Remodelling of the angular collagen fiber distribution in cardiovascular tissues. Biomech Model Mechanobiol (2007) 1.00
VEGF profiling and angiogenesis in human microtissues. J Biotechnol (2005) 1.00
Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Ann Biomed Eng (2007) 0.99
Modeling the mechanics of tissue-engineered human heart valve leaflets. J Biomech (2006) 0.98
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J (2011) 0.97
Mechanical characterization of anisotropic planar biological soft tissues using large indentation: a computational feasibility study. J Biomech Eng (2006) 0.96
The influence of serum-free culture conditions on skeletal muscle differentiation in a tissue-engineered model. Tissue Eng Part A (2008) 0.96
Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg (2004) 0.95
Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng (2006) 0.95
Effects of a combined mechanical stimulation protocol: Value for skeletal muscle tissue engineering. J Biomech (2010) 0.95
Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg (2006) 0.94
Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation (2007) 0.94
Intermittent straining accelerates the development of tissue properties in engineered heart valve tissue. Tissue Eng Part A (2009) 0.94
The relative contributions of compression and hypoxia to development of muscle tissue damage: an in vitro study. Ann Biomed Eng (2006) 0.94
Human umbilical cord cells: a new cell source for cardiovascular tissue engineering. Ann Thorac Surg (2002) 0.93
Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur Heart J (2011) 0.93
Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis (2008) 0.92
Osmoviscoelastic finite element model of the intervertebral disc. Eur Spine J (2006) 0.92
Hypoxia induces near-native mechanical properties in engineered heart valve tissue. Circulation (2008) 0.92
Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci (2007) 0.92
The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng Part A (2013) 0.91
Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol (2011) 0.90
Stabilised beta-catenin in postnatal ventricular myocardium leads to dilated cardiomyopathy and premature death. Basic Res Cardiol (2010) 0.90
Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg (2005) 0.90
Tissue-engineered heart valves develop native-like collagen fiber architecture. Tissue Eng Part A (2010) 0.90
Stress related collagen ultrastructure in human aortic valves--implications for tissue engineering. J Biomech (2008) 0.90
Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart. Biomaterials (2013) 0.89
Local axial compressive mechanical properties of human carotid atherosclerotic plaques-characterisation by indentation test and inverse finite element analysis. J Biomech (2013) 0.89
Osteoblasts response to allogenic and xenogenic solvent dehydrated cancellous bone in vitro. Biomaterials (2003) 0.89
The influence of matrix integrity on stress-fiber remodeling in 3D. Biomaterials (2012) 0.89
Heart valve tissue engineering. Transpl Immunol (2004) 0.89
Mechanoregulation of vascularization in aligned tissue-engineered muscle: a role for vascular endothelial growth factor. Tissue Eng Part A (2011) 0.89
Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur J Cardiothorac Surg (2004) 0.89
Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies. Biomaterials (2013) 0.88
Strain-induced collagen organization at the micro-level in fibrin-based engineered tissue constructs. Ann Biomed Eng (2012) 0.88
A new source for cardiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg (2002) 0.88
Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations. Nucleus (2013) 0.88
A microstructurally motivated model of the mechanical behavior of tissue engineered blood vessels. Ann Biomed Eng (2008) 0.88
Engineering skeletal muscle tissues from murine myoblast progenitor cells and application of electrical stimulation. J Vis Exp (2013) 0.87
Temporal differences in the influence of ischemic factors and deformation on the metabolism of engineered skeletal muscle. J Appl Physiol (1985) (2007) 0.87
Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials (2012) 0.87
Application of stereolithography for scaffold fabrication for tissue engineered heart valves. ASAIO J (2002) 0.86
Tissue engineered heart valves based on human cells. Swiss Med Wkly (2006) 0.86
An in vitro model system to quantify stress generation, compaction, and retraction in engineered heart valve tissue. Tissue Eng Part C Methods (2011) 0.86
Influence of bone marrow fat embolism on coagulation activation in an ovine model of vertebroplasty. J Bone Joint Surg Am (2008) 0.86
Tissue-engineered trachea: History, problems and the future. Eur J Cardiothorac Surg (2006) 0.86
Sildenafil prevents cardiovascular changes after bone marrow fat embolization in sheep. Anesthesiology (2007) 0.86
Stem cells for heart valve regeneration. Swiss Med Wkly (2012) 0.85
Viscoelastic properties of single attached cells under compression. J Biomech Eng (2005) 0.85
Monitoring local cell viability in engineered tissues: a fast, quantitative, and nondestructive approach. Tissue Eng (2003) 0.85
Are disc pressure, stress, and osmolarity affected by intra- and extrafibrillar fluid exchange? J Orthop Res (2007) 0.84
Influence of substrate stiffness on circulating progenitor cell fate. J Biomech (2011) 0.84
EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol (2010) 0.84
Anisotropic, three-dimensional deformation of single attached cells under compression. Ann Biomed Eng (2004) 0.84
Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases. Eur J Cardiothorac Surg (2012) 0.83
Routine off-pump coronary artery bypass grafting is safe and feasible in high-risk patients with left main disease. Ann Thorac Surg (2010) 0.83
Cardiovascular tissue engineering: a new laminar flow chamber for in vitro improvement of mechanical tissue properties. ASAIO J (2002) 0.83
Mechanisms that play a role in the maintenance of the calcium gradient in the epidermis. Skin Res Technol (2007) 0.83
Transapical aortic implantation of autologous marrow stromal cell-based tissue-engineered heart valves: first experiences in the systemic circulation. JACC Cardiovasc Interv (2011) 0.83
The transport profile of cytokines in epidermal equivalents subjected to mechanical loading. Ann Biomed Eng (2009) 0.83
Evaluation of a continuous quantification method of apoptosis and necrosis in tissue cultures. Cytotechnology (2005) 0.83
Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts. Tissue Eng Part A (2009) 0.82
Controlling matrix formation and cross-linking by hypoxia in cardiovascular tissue engineering. J Appl Physiol (1985) (2010) 0.82